Outbreak of Infection by Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-58 in Belgium-Reference-Cited by-同舟云学术

Outbreak of Infection by Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-58 in Belgium

Published:2006-11 Issue:11 Volume:44 Page:4189-4192
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Bogaerts Pierre¹,Naas Thierry²,Wybo Ingrid³,Bauraing Caroline¹,Soetens Oriane³,Piérard Denis³,Nordmann Patrice²,Glupczynski Youri¹

Affiliation:

1. Laboratoire de Bactériologie, Cliniques Universitaires UCL de Mont-Godinne, B-5530 Yvoir, Belgium

2. Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Paris-Sud, Université Paris XI, Le Kremlin-Bicêtre, France

3. Dienst Microbiologie en Ziekenhuishygiëne, Academisch Ziekenhuis Vrije Universiteit Brussel, B-1090 Brussels, Belgium

Abstract

ABSTRACT Carbapenem-resistant Acinetobacter baumannii isolates were obtained from 17 patients between September 2004 and August 2005 at the Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium. These multidrug-resistant isolates, which belonged to a single clone, remained susceptible to colistin and tigecycline only and produced the carbapenem-hydrolyzing oxacillinase OXA-58. This study highlights the importance of the intercountry spread of this β-lactamase-mediated resistance mechanism and its epidemic evolution.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00796-06

Reference24 articles.

1. Characterization of OXA-25, OXA-26, and OXA-27, Molecular Class D β-Lactamases Associated with Carbapenem Resistance in Clinical Isolates of Acinetobacter baumannii

2. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features

3. Brown, S., and S. Amyes. 2006. OXA β-lactamases in Acinetobacter: the story so far. J. Antimicrob. Chemother.57:1-3.

4. Brown, S., H. K. Young, and S. G. B. Amyes. 2005. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect.11:11-15.

5. Clark, R. B. 1996. Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein. J. Antimicrob. Chemother.38:245-251.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-transmission of Acinetobacter junii carrying blaOXA-58 in a neonatal ICU;Journal of Antimicrobial Chemotherapy;2024-07-03

2. Exploring the metabolic profiling ofA. baumanniifor antimicrobial development using genome-scale modeling;2023-09-15

3. Genomic Analysis of a Strain Collection Containing Multidrug-, Extensively Drug-, Pandrug-, and Carbapenem-Resistant Modern Clinical Isolates of Acinetobacter baumannii;Antimicrobial Agents and Chemotherapy;2022-09-20

4. Investigation of Tigecycline Susceptibility of Multidrug-Resistant Acinetobacter Baumannii Isolates by Disc Diffusion, Agar Gradient and Broth Microdilution Tests;Acta Clinica Croatica;2022

5. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals;Molecular Biology Reports;2021-08-30